News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Harrington-Smith Kristen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/24/2023 |
4
| Harrington-Smith Kristen (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 28,125 options to buy
@ $0.4688, valued at
$13.2k
|
|
| 11/18/2022 |
4
| Harrington-Smith Kristen (SVP & CHIEF COMMERCIAL OFFICER) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Exercised 25,000 restricted stock units
@ $0 |
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Harrington-Smith Kristen (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $4.61, valued at
$184.4k
|
|
| 02/17/2022 |
3
| Harrington-Smith Kristen (Director) has filed a Form 3 on eFFECTOR Therapeutics, Inc. |
| 11/17/2021 |
4
| Harrington-Smith Kristen (SVP & Chief Commercial Officer) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 75,000 restricted stock units
@ $0
Granted 450,000 options to buy
@ $5.68, valued at
$2.6M
|
|
| 11/17/2021 |
3
| Harrington-Smith Kristen (SVP & Chief Commercial Officer) has filed a Form 3 on ImmunoGen, Inc. |
|
|